Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. has successfully conducted its 2024 Annual General Meeting and class meetings for A and H shareholders, with key resolutions—such as the approval of the Board’s work report, financial statements, and the appointment of auditors for the upcoming year—passed overwhelmingly by attending shareholders. Notably, a significant majority of the company’s voting shares were represented, with over 66% attending the AGM and more than 77% and 19% of A and H shares represented at their respective class meetings.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.
